Clinical outcome of gemcitabine and carboplatin as second-line chemotherapy for advanced urothelial carcinoma resistant to first-line therapy with methotrexate, vinblastine, doxorubicin, and cisplatin

• J. Furukawa,
• T Terakawa,
• K. Harada,
• N. Hinata,
• F. Masato

Affiliations

J. Furukawa

T Terakawa

K. Harada

N. Hinata

F. Masato